2010
DOI: 10.1101/gad.1903410
|View full text |Cite
|
Sign up to set email alerts
|

Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis

Abstract: Oncogene-mediated transformation of hematopoietic cells has been studied extensively, but little is known about the molecular basis for restriction of oncogenes to certain target cells and differential cellular context-specific requirements for oncogenic transformation between infant and adult leukemias. Understanding cell type-specific interplay of signaling pathways and oncogenes is essential for developing targeted cancer therapies. Here, we address the vexing issue of how developmental restriction is achie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
168
2
6

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 132 publications
(182 citation statements)
references
References 54 publications
6
168
2
6
Order By: Relevance
“…In addition, we show that GATA1s enhances human megakaryocyte and myeloid expansion, which likely contributes to the development of DS-associated myeloproliferative disorders. A LXCXE motif within the N-terminus of GATA1 (amino acids 81-85) binds Rb-E2F transcription factor family members, which inhibits the expression of genes that stimulate cell proliferation (56,65). Studies of GATA1 alleles in DS-TMD patients, including rare cases with mutations that produce internal protein deletions (66), map a minimal disease-associated domain to within amino acids 74-83, which includes the Rb-binding motif.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, we show that GATA1s enhances human megakaryocyte and myeloid expansion, which likely contributes to the development of DS-associated myeloproliferative disorders. A LXCXE motif within the N-terminus of GATA1 (amino acids 81-85) binds Rb-E2F transcription factor family members, which inhibits the expression of genes that stimulate cell proliferation (56,65). Studies of GATA1 alleles in DS-TMD patients, including rare cases with mutations that produce internal protein deletions (66), map a minimal disease-associated domain to within amino acids 74-83, which includes the Rb-binding motif.…”
Section: Discussionmentioning
confidence: 99%
“…47 Loss of the Rb interaction is also thought to contribute to leukemic transformation in DS-AMKL through increased E2F activity. 48 It is possible that there are multiple factors that contribute to the erythroid specific deficiency caused by GATA1s mutations. A promising candidate is LMO2, a component of the SCL pentameric complex, which is known to co-operate with GATA1 in gene activation but not gene repression.…”
Section: A B Cmentioning
confidence: 99%
“…FL CD34 + HSPCs were purchased from Novogenic Laboratories. Culture conditions for maintenance, megakaryocytic, or megakaryocytic/erythroid in vitro differentiation of CD34 + HSPCs were described elsewhere (Klusmann et al 2010a;Kumar et al 2011;Emmrich et al 2012;Stankov et al 2014). Cell lines (CMK, K562, MV4:11, THP-1, and NB4) were purchased from the German National Resource Center for Biological Material (DSMZ) and maintained under recommended conditions.…”
Section: Patient Samples and Cell Linesmentioning
confidence: 99%